English

Arcturus Therapeutics Ltd.

EDGAR

ADHD Quarterly report (10-Q) · filed 2019-05-13

116 filing records in this dataset, filed from 2013-01-14 to 2019-05-13. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

4.35 million USD

2019 Q1 · USD

Exact inputs and evidence

Revenue: 4350000 USD Source

Operating margin

-149.61%

2019 Q1 · %

Exact inputs and evidence

Operating Income: -6508000 USD Source
Revenue: 4350000 USD Source

Operating cash flow

-5.41 million USD

2019 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -5411000 USD Source

Free cash flow

-5.49 million USD

2019 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -5411000 USD Source
Capital Expenditure: 78000 USD Source

Cash and cash equivalents: 31.2 million USD 2019-03-31 Source
Exact value

31220000 USD
Long-term debt including current maturities: 10.3 million USD 2018-12-31 Source
Exact value

10300000 USD
Shares outstanding: 10.7 million shares 2019-03-31 Source
Exact value

10719000 shares

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

17.7 million USD

2018-04-01 – 2019-03-31

Exact inputs and evidence

Revenue: 2386000 USD · 2018-04-01 – 2018-06-30 Source
Revenue: 3423000 USD · 2018-07-01 – 2018-09-30 Source
Revenue: 15753000 USD · 2018-01-01 – 2018-12-31 Source
Revenue: 8176000 USD · 2018-01-01 – 2018-09-30 Source
Revenue: 4350000 USD · 2019-01-01 – 2019-03-31 Source

Net income

-22.1 million USD

2018-04-01 – 2019-03-31

Exact inputs and evidence

Net income: -9950000 USD · 2018-04-01 – 2018-06-30 Source
Net income: -4253000 USD · 2018-07-01 – 2018-09-30 Source
Net income: -21785000 USD · 2018-01-01 – 2018-12-31 Source
Net income: -20774000 USD · 2018-01-01 – 2018-09-30 Source
Net income: -6884000 USD · 2019-01-01 – 2019-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2019-05-13.

Financial data available through: 2018-12-31.

Coverage by financial measure

Revenue: 4 of 11 periods available· newest 2018-12-31
Operating income: 8 of 11 periods available· newest 2018-12-31
Net income: 10 of 11 periods available· newest 2018-12-31
Operating cash flow: 8 of 11 periods available· newest 2018-12-31
Capital expenditure: 8 of 11 periods available· newest 2018-12-31
Total assets: 4 of 11 periods available· newest 2018-12-31
Total liabilities: 3 of 11 periods available· newest 2018-12-31
Current assets: 4 of 11 periods available· newest 2018-12-31
Current liabilities: 4 of 11 periods available· newest 2018-12-31
Cash and cash equivalents: 4 of 11 periods available· newest 2018-12-31
Long-term debt including current maturities: 1 of 11 periods available· newest 2018-12-31
Shares outstanding: 4 of 11 periods available· newest 2018-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+21.2%

Prior period

USD 13 million

2017-01-01 – 2017-12-31
Current period

USD 15.75 million

2018-01-01 – 2018-12-31

Exact inputs and evidence

15753000 − 12998000 = 2755000 USD

12998000 USD · 2017-01-01 – 2017-12-31
Inspect prior input Prior source
15753000 USD · 2018-01-01 – 2018-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Arcturus Therapeutics Ltd. · 2018-12-31 Arcturus Therapeutics Ltd. (edgar:1566049) Year-over-year change in Revenue: 2755000 USD Concept: fundies:Revenue Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-04T08:20:02Z Snapshot: 04d173d115a783f66d72451f6752cdaff97f8c2503eee9d0f6fa24700edc3e3f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1566049?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 15753000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000119312519077140/arct-20181231.xml#125530 Filing: 000119312519077140 Input fundies:Revenue: 12998000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000119312519077140/arct-20181231.xml#125672 Filing: 000119312519077140
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 10.88 million

Prior period

−USD 10.9 million

2017-01-01 – 2017-12-31
Current period

−USD 21.79 million

2018-01-01 – 2018-12-31

Exact inputs and evidence

-21785000 − -10902000 = -10883000 USD

-10902000 USD · 2017-01-01 – 2017-12-31
Inspect prior input Prior source
-21785000 USD · 2018-01-01 – 2018-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Arcturus Therapeutics Ltd. · 2018-12-31 Arcturus Therapeutics Ltd. (edgar:1566049) Year-over-year change in Net income: -10883000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-04T08:20:02Z Snapshot: 04d173d115a783f66d72451f6752cdaff97f8c2503eee9d0f6fa24700edc3e3f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1566049?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -21785000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000119312519077140/arct-20181231.xml#128561 Filing: 000119312519077140 Input fundies:NetIncome: -10902000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000119312519077140/arct-20181231.xml#128714 Filing: 000119312519077140
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 20.3 million

Prior period

−USD 460,000

2017-01-01 – 2017-12-31
Current period

−USD 20.76 million

2018-01-01 – 2018-12-31

Exact inputs and evidence

-20760000 − -460000 = -20300000 USD

-460000 USD · 2017-01-01 – 2017-12-31
Inspect prior input Prior source
-20760000 USD · 2018-01-01 – 2018-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Arcturus Therapeutics Ltd. · 2018-12-31 Arcturus Therapeutics Ltd. (edgar:1566049) Year-over-year change in Operating cash flow: -20300000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-04T08:20:02Z Snapshot: 04d173d115a783f66d72451f6752cdaff97f8c2503eee9d0f6fa24700edc3e3f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1566049?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -20760000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000119312519077140/arct-20181231.xml#145873 Filing: 000119312519077140 Input fundies:OperatingCashFlow: -460000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000119312519077140/arct-20181231.xml#146084 Filing: 000119312519077140
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+488.8%

Prior period

USD 251,000

2017-01-01 – 2017-12-31
Current period

USD 1.48 million

2018-01-01 – 2018-12-31

Exact inputs and evidence

1478000 − 251000 = 1227000 USD

251000 USD · 2017-01-01 – 2017-12-31
Inspect prior input Prior source
1478000 USD · 2018-01-01 – 2018-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Arcturus Therapeutics Ltd. · 2018-12-31 Arcturus Therapeutics Ltd. (edgar:1566049) Year-over-year change in Capital expenditure: 1227000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-04T08:20:02Z Snapshot: 04d173d115a783f66d72451f6752cdaff97f8c2503eee9d0f6fa24700edc3e3f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1566049?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 1478000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000119312519077140/arct-20181231.xml#146293 Filing: 000119312519077140 Input fundies:CapitalExpenditure: 251000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000119312519077140/arct-20181231.xml#146502 Filing: 000119312519077140
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2018 2018-01-01 – 2018-12-31

Revenue USD 15.75 million 100% of revenue
Operating costs Derived USD 37.56 million 238% of revenue
Operating income −USD 21.81 million −138% of revenue
Tax, interest and other Derived −USD 26,000 −0.2% of revenue
Net income −USD 21.79 million −138% of revenue

Cash

Operating cash flow −USD 20.76 million −132% of revenue
Capital expenditure USD 1.48 million 9.4% of revenue
Free cash flow Derived −USD 22.24 million −141% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2015 Operating loss: operating costs were 131% of revenue.
2016 Operating loss: operating costs were 105% of revenue.
2017 Operating loss: operating costs were 181% of revenue.
2018 Operating loss: operating costs were 238% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2015 2015-01-01 – 2015-12-31	6138000	8050000 Derived	-1912000	-10000 Derived	-1902000	8043000 Derived	Source 2015-01-01 – 2015-12-31: 6138000 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: -1912000 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: -1902000 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: 8290000 USD Inspect Operating Cash Flow Open source 2015-01-01 – 2015-12-31: 247000 USD Inspect Capital Expenditure Open source
2016 2016-01-01 – 2016-12-31	20382000	21382000 Derived	-1000000	571000 Derived	-1571000	-3549000 Derived	Source 2016-01-01 – 2016-12-31: 20382000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -1000000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -1571000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -2861000 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 688000 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	12998000	23490000 Derived	-10492000	410000 Derived	-10902000	-711000 Derived	Source 2017-01-01 – 2017-12-31: 12998000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -10492000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -10902000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -460000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 251000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	15753000	37564000 Derived	-21811000	-26000 Derived	-21785000	-22238000 Derived	Source 2018-01-01 – 2018-12-31: 15753000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -21811000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -21785000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -20760000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 1478000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 15.8M 2018

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Revenue	6138000	Revenue: 6138000 Open source
20162016-12-31	Revenue	20382000	Revenue: 20382000 Open source
20172017-12-31	Revenue	12998000	Revenue: 12998000 Open source
20182018-12-31	Revenue	15753000	Revenue: 15753000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

21.2% 2018

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Year over year	No prior comparable period	Revenue: 6138000 Open source
20162016-12-31	Year over year	232.1%	Revenue: 20382000 Open source Revenue: 6138000 Open source
20172017-12-31	Year over year	-36.2%	Revenue: 12998000 Open source Revenue: 20382000 Open source
20182018-12-31	Year over year	21.2%	Revenue: 15753000 Open source Revenue: 12998000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -138.5% 2018

Net margin -138.3% 2018

Free cash flow margin -141.2% 2018

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Operating margin	-31.2%	Operating Income: -1912000 Open source Revenue: 6138000 Open source
20162016-12-31	Operating margin	-4.9%	Operating Income: -1000000 Open source Revenue: 20382000 Open source
20172017-12-31	Operating margin	-80.7%	Operating Income: -10492000 Open source Revenue: 12998000 Open source
20182018-12-31	Operating margin	-138.5%	Operating Income: -21811000 Open source Revenue: 15753000 Open source
20152015-12-31	Net margin	-31%	Net Income: -1902000 Open source Revenue: 6138000 Open source
20162016-12-31	Net margin	-7.7%	Net Income: -1571000 Open source Revenue: 20382000 Open source
20172017-12-31	Net margin	-83.9%	Net Income: -10902000 Open source Revenue: 12998000 Open source
20182018-12-31	Net margin	-138.3%	Net Income: -21785000 Open source Revenue: 15753000 Open source
20152015-12-31	Free cash flow margin	131%	Revenue: 6138000 Open source Operating Cash Flow: 8290000 Open source Capital Expenditure: 247000 Open source
20162016-12-31	Free cash flow margin	-17.4%	Revenue: 20382000 Open source Operating Cash Flow: -2861000 Open source Capital Expenditure: 688000 Open source
20172017-12-31	Free cash flow margin	-5.5%	Revenue: 12998000 Open source Operating Cash Flow: -460000 Open source Capital Expenditure: 251000 Open source
20182018-12-31	Free cash flow margin	-141.2%	Revenue: 15753000 Open source Operating Cash Flow: -20760000 Open source Capital Expenditure: 1478000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -20.8M 2018

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Operating cash flow	8290000	Operating Cash Flow: 8290000 Open source
20162016-12-31	Operating cash flow	-2861000	Operating Cash Flow: -2861000 Open source
20172017-12-31	Operating cash flow	-460000	Operating Cash Flow: -460000 Open source
20182018-12-31	Operating cash flow	-20760000	Operating Cash Flow: -20760000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -22.2M 2018

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Free cash flow	8043000	Operating Cash Flow: 8290000 Open source Capital Expenditure: 247000 Open source
20162016-12-31	Free cash flow	-3549000	Operating Cash Flow: -2861000 Open source Capital Expenditure: 688000 Open source
20172017-12-31	Free cash flow	-711000	Operating Cash Flow: -460000 Open source Capital Expenditure: 251000 Open source
20182018-12-31	Free cash flow	-22238000	Operating Cash Flow: -20760000 Open source Capital Expenditure: 1478000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

69.1% 2018

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2015-12-31	Liabilities / assets	Not reported	Total Assets: 71683000 Open source
20162016-12-31	Liabilities / assets	88.5%	Total Liabilities: 12159000 Open source Total Assets: 13736000 Open source
20172017-12-31	Liabilities / assets	35%	Total Liabilities: 18230000 Open source Total Assets: 52024000 Open source
20182018-12-31	Liabilities / assets	69.1%	Total Liabilities: 30556000 Open source Total Assets: 44198000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

3.33× 2018

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Current assets / current liabilities	22.26×	Current Assets: 52346000 Open source Current Liabilities: 2352000 Open source
20162016-12-31	Current assets / current liabilities	1.41×	Current Assets: 12331000 Open source Current Liabilities: 8734000 Open source
20172017-12-31	Current assets / current liabilities	4.61×	Current Assets: 50868000 Open source Current Liabilities: 11040000 Open source
20182018-12-31	Current assets / current liabilities	3.33×	Current Assets: 41828000 Open source Current Liabilities: 12577000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2009 2009-01-01 – 2009-12-31	−USD 608,000 Exact value Exact value: -608000 USD 2009-01-01 – 2009-12-31: -608000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Arcturus Therapeutics Ltd. · 2009-12-31 Arcturus Therapeutics Ltd. (edgar:1566049) Net Income: -608000 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-04T08:20:02Z Snapshot: 04d173d115a783f66d72451f6752cdaff97f8c2503eee9d0f6fa24700edc3e3f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1566049/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -608000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000114420414018739/adhd-20131231.xml#958811 Filing: 000114420414018739 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2010 2010-01-01 – 2010-12-31	−USD 1.22 million Exact value Exact value: -1224000 USD 2010-01-01 – 2010-12-31: -1224000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Arcturus Therapeutics Ltd. · 2010-12-31 Arcturus Therapeutics Ltd. (edgar:1566049) Net Income: -1224000 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-04T08:20:02Z Snapshot: 04d173d115a783f66d72451f6752cdaff97f8c2503eee9d0f6fa24700edc3e3f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1566049/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1224000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000114420414018739/adhd-20131231.xml#960039 Filing: 000114420414018739 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2011 2011-01-01 – 2011-12-31	−USD 3.93 million Exact value Exact value: -3929000 USD 2011-01-01 – 2011-12-31: -3929000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Arcturus Therapeutics Ltd. · 2011-12-31 Arcturus Therapeutics Ltd. (edgar:1566049) Net Income: -3929000 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-04T08:20:02Z Snapshot: 04d173d115a783f66d72451f6752cdaff97f8c2503eee9d0f6fa24700edc3e3f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1566049/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3929000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000114420414018739/adhd-20131231.xml#858126 Filing: 000114420414018739 The citation records this snapshot. The page link may show a newer release later.	−USD 2.36 million Exact value Exact value: -2361000 USD 2011-01-01 – 2011-12-31: -2361000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Arcturus Therapeutics Ltd. · 2011-12-31 Arcturus Therapeutics Ltd. (edgar:1566049) Operating Cash Flow: -2361000 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-04T08:20:02Z Snapshot: 04d173d115a783f66d72451f6752cdaff97f8c2503eee9d0f6fa24700edc3e3f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1566049/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2361000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000114420414018739/adhd-20131231.xml#989393 Filing: 000114420414018739 The citation records this snapshot. The page link may show a newer release later.	USD 24,000 Exact value Exact value: 24000 USD 2011-01-01 – 2011-12-31: 24000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Arcturus Therapeutics Ltd. · 2011-12-31 Arcturus Therapeutics Ltd. (edgar:1566049) Capital Expenditure: 24000 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-04T08:20:02Z Snapshot: 04d173d115a783f66d72451f6752cdaff97f8c2503eee9d0f6fa24700edc3e3f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1566049/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 24000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000114420414018739/adhd-20131231.xml#990186 Filing: 000114420414018739 The citation records this snapshot. The page link may show a newer release later.	−USD 2.39 million Calculation and evidence -2361000 − 24000 USD Exact free cash flow: -2385000 USD 2011-01-01 – 2011-12-31: -2361000 USD · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 24000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Arcturus Therapeutics Ltd. · 2011-12-31 Arcturus Therapeutics Ltd. (edgar:1566049) Free cash flow: -2385000 USD Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-04T08:20:02Z Snapshot: 04d173d115a783f66d72451f6752cdaff97f8c2503eee9d0f6fa24700edc3e3f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1566049?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2361000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000114420414018739/adhd-20131231.xml#989393 Filing: 000114420414018739 Input fundies:CapitalExpenditure: 24000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000114420414018739/adhd-20131231.xml#990186 Filing: 000114420414018739 The citation records this snapshot. The page link may show a newer release later.
2012 2012-01-01 – 2012-12-31	−USD 1.58 million Exact value Exact value: -1579000 USD 2012-01-01 – 2012-12-31: -1579000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Arcturus Therapeutics Ltd. · 2012-12-31 Arcturus Therapeutics Ltd. (edgar:1566049) Net Income: -1579000 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-04T08:20:02Z Snapshot: 04d173d115a783f66d72451f6752cdaff97f8c2503eee9d0f6fa24700edc3e3f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1566049/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1579000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000114420415012776/adhd-20141231.xml#63276 Filing: 000114420415012776 The citation records this snapshot. The page link may show a newer release later.	−USD 1.58 million Exact value Exact value: -1583000 USD 2012-01-01 – 2012-12-31: -1583000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Arcturus Therapeutics Ltd. · 2012-12-31 Arcturus Therapeutics Ltd. (edgar:1566049) Operating Cash Flow: -1583000 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-04T08:20:02Z Snapshot: 04d173d115a783f66d72451f6752cdaff97f8c2503eee9d0f6fa24700edc3e3f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1566049/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1583000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000114420415012776/adhd-20141231.xml#69426 Filing: 000114420415012776 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2012-01-01 – 2012-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Arcturus Therapeutics Ltd. · 2012-12-31 Arcturus Therapeutics Ltd. (edgar:1566049) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-04T08:20:02Z Snapshot: 04d173d115a783f66d72451f6752cdaff97f8c2503eee9d0f6fa24700edc3e3f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1566049/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000114420415012776/adhd-20141231.xml#70011 Filing: 000114420415012776 The citation records this snapshot. The page link may show a newer release later.	−USD 1.58 million Calculation and evidence -1583000 − 0 USD Exact free cash flow: -1583000 USD 2012-01-01 – 2012-12-31: -1583000 USD · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Arcturus Therapeutics Ltd. · 2012-12-31 Arcturus Therapeutics Ltd. (edgar:1566049) Free cash flow: -1583000 USD Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-04T08:20:02Z Snapshot: 04d173d115a783f66d72451f6752cdaff97f8c2503eee9d0f6fa24700edc3e3f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1566049?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1583000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000114420415012776/adhd-20141231.xml#69426 Filing: 000114420415012776 Input fundies:CapitalExpenditure: 0 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000114420415012776/adhd-20141231.xml#70011 Filing: 000114420415012776 The citation records this snapshot. The page link may show a newer release later.
2013 2013-01-01 – 2013-12-31	−USD 10.55 million Exact value Exact value: -10548000 USD 2013-01-01 – 2013-12-31: -10548000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Arcturus Therapeutics Ltd. · 2013-12-31 Arcturus Therapeutics Ltd. (edgar:1566049) Net Income: -10548000 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-04T08:20:02Z Snapshot: 04d173d115a783f66d72451f6752cdaff97f8c2503eee9d0f6fa24700edc3e3f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1566049/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -10548000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000114420416086094/adhd-20151231.xml#75753 Filing: 000114420416086094 The citation records this snapshot. The page link may show a newer release later.	−USD 7.35 million Exact value Exact value: -7353000 USD 2013-01-01 – 2013-12-31: -7353000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Arcturus Therapeutics Ltd. · 2013-12-31 Arcturus Therapeutics Ltd. (edgar:1566049) Operating Cash Flow: -7353000 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-04T08:20:02Z Snapshot: 04d173d115a783f66d72451f6752cdaff97f8c2503eee9d0f6fa24700edc3e3f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1566049/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7353000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000114420416086094/adhd-20151231.xml#90782 Filing: 000114420416086094 The citation records this snapshot. The page link may show a newer release later.	USD 39,000 Exact value Exact value: 39000 USD 2013-01-01 – 2013-12-31: 39000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Arcturus Therapeutics Ltd. · 2013-12-31 Arcturus Therapeutics Ltd. (edgar:1566049) Capital Expenditure: 39000 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-04T08:20:02Z Snapshot: 04d173d115a783f66d72451f6752cdaff97f8c2503eee9d0f6fa24700edc3e3f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1566049/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 39000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000114420416086094/adhd-20151231.xml#91371 Filing: 000114420416086094 The citation records this snapshot. The page link may show a newer release later.	−USD 7.39 million Calculation and evidence -7353000 − 39000 USD Exact free cash flow: -7392000 USD 2013-01-01 – 2013-12-31: -7353000 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 39000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Arcturus Therapeutics Ltd. · 2013-12-31 Arcturus Therapeutics Ltd. (edgar:1566049) Free cash flow: -7392000 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-04T08:20:02Z Snapshot: 04d173d115a783f66d72451f6752cdaff97f8c2503eee9d0f6fa24700edc3e3f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1566049?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7353000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000114420416086094/adhd-20151231.xml#90782 Filing: 000114420416086094 Input fundies:CapitalExpenditure: 39000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000114420416086094/adhd-20151231.xml#91371 Filing: 000114420416086094 The citation records this snapshot. The page link may show a newer release later.
2014 2014-01-01 – 2014-12-31	−USD 32.83 million Exact value Exact value: -32834000 USD 2014-01-01 – 2014-12-31: -32834000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Arcturus Therapeutics Ltd. · 2014-12-31 Arcturus Therapeutics Ltd. (edgar:1566049) Net Income: -32834000 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-04T08:20:02Z Snapshot: 04d173d115a783f66d72451f6752cdaff97f8c2503eee9d0f6fa24700edc3e3f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1566049/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -32834000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000114420417023306/adhd-20161231.xml#712255 Filing: 000114420417023306 The citation records this snapshot. The page link may show a newer release later.	−USD 28.33 million Exact value Exact value: -28326000 USD 2014-01-01 – 2014-12-31: -28326000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Arcturus Therapeutics Ltd. · 2014-12-31 Arcturus Therapeutics Ltd. (edgar:1566049) Operating Cash Flow: -28326000 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-04T08:20:02Z Snapshot: 04d173d115a783f66d72451f6752cdaff97f8c2503eee9d0f6fa24700edc3e3f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1566049/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -28326000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000114420417023306/adhd-20161231.xml#716275 Filing: 000114420417023306 The citation records this snapshot. The page link may show a newer release later.	USD 79,000 Exact value Exact value: 79000 USD 2014-01-01 – 2014-12-31: 79000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Arcturus Therapeutics Ltd. · 2014-12-31 Arcturus Therapeutics Ltd. (edgar:1566049) Capital Expenditure: 79000 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-04T08:20:02Z Snapshot: 04d173d115a783f66d72451f6752cdaff97f8c2503eee9d0f6fa24700edc3e3f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1566049/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 79000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000114420417023306/adhd-20161231.xml#716670 Filing: 000114420417023306 The citation records this snapshot. The page link may show a newer release later.	−USD 28.41 million Calculation and evidence -28326000 − 79000 USD Exact free cash flow: -28405000 USD 2014-01-01 – 2014-12-31: -28326000 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 79000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Arcturus Therapeutics Ltd. · 2014-12-31 Arcturus Therapeutics Ltd. (edgar:1566049) Free cash flow: -28405000 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-04T08:20:02Z Snapshot: 04d173d115a783f66d72451f6752cdaff97f8c2503eee9d0f6fa24700edc3e3f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1566049?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -28326000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000114420417023306/adhd-20161231.xml#716275 Filing: 000114420417023306 Input fundies:CapitalExpenditure: 79000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000114420417023306/adhd-20161231.xml#716670 Filing: 000114420417023306 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	−USD 1.9 million Exact value Exact value: -1902000 USD 2015-01-01 – 2015-12-31: -1902000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Arcturus Therapeutics Ltd. · 2015-12-31 Arcturus Therapeutics Ltd. (edgar:1566049) Net Income: -1902000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-04T08:20:02Z Snapshot: 04d173d115a783f66d72451f6752cdaff97f8c2503eee9d0f6fa24700edc3e3f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1566049/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1902000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000156459018013460/arct-20171231.xml#121301 Filing: 000156459018013460 The citation records this snapshot. The page link may show a newer release later.	USD 8.29 million Exact value Exact value: 8290000 USD 2015-01-01 – 2015-12-31: 8290000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Arcturus Therapeutics Ltd. · 2015-12-31 Arcturus Therapeutics Ltd. (edgar:1566049) Operating Cash Flow: 8290000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-04T08:20:02Z Snapshot: 04d173d115a783f66d72451f6752cdaff97f8c2503eee9d0f6fa24700edc3e3f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1566049/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 8290000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000156459018013460/arct-20171231.xml#143953 Filing: 000156459018013460 The citation records this snapshot. The page link may show a newer release later.	USD 247,000 Exact value Exact value: 247000 USD 2015-01-01 – 2015-12-31: 247000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Arcturus Therapeutics Ltd. · 2015-12-31 Arcturus Therapeutics Ltd. (edgar:1566049) Capital Expenditure: 247000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-04T08:20:02Z Snapshot: 04d173d115a783f66d72451f6752cdaff97f8c2503eee9d0f6fa24700edc3e3f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1566049/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 247000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000156459018013460/arct-20171231.xml#144874 Filing: 000156459018013460 The citation records this snapshot. The page link may show a newer release later.	USD 8.04 million Calculation and evidence 8290000 − 247000 USD Exact free cash flow: 8043000 USD 2015-01-01 – 2015-12-31: 8290000 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 247000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Arcturus Therapeutics Ltd. · 2015-12-31 Arcturus Therapeutics Ltd. (edgar:1566049) Free cash flow: 8043000 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-04T08:20:02Z Snapshot: 04d173d115a783f66d72451f6752cdaff97f8c2503eee9d0f6fa24700edc3e3f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1566049?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 8290000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000156459018013460/arct-20171231.xml#143953 Filing: 000156459018013460 Input fundies:CapitalExpenditure: 247000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000156459018013460/arct-20171231.xml#144874 Filing: 000156459018013460 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	−USD 1.57 million Exact value Exact value: -1571000 USD 2016-01-01 – 2016-12-31: -1571000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Arcturus Therapeutics Ltd. · 2016-12-31 Arcturus Therapeutics Ltd. (edgar:1566049) Net Income: -1571000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-04T08:20:02Z Snapshot: 04d173d115a783f66d72451f6752cdaff97f8c2503eee9d0f6fa24700edc3e3f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1566049/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1571000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000156459018013460/arct-20171231.xml#121148 Filing: 000156459018013460 The citation records this snapshot. The page link may show a newer release later.	−USD 2.86 million Exact value Exact value: -2861000 USD 2016-01-01 – 2016-12-31: -2861000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Arcturus Therapeutics Ltd. · 2016-12-31 Arcturus Therapeutics Ltd. (edgar:1566049) Operating Cash Flow: -2861000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-04T08:20:02Z Snapshot: 04d173d115a783f66d72451f6752cdaff97f8c2503eee9d0f6fa24700edc3e3f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1566049/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2861000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000156459018013460/arct-20171231.xml#143702 Filing: 000156459018013460 The citation records this snapshot. The page link may show a newer release later.	USD 688,000 Exact value Exact value: 688000 USD 2016-01-01 – 2016-12-31: 688000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Arcturus Therapeutics Ltd. · 2016-12-31 Arcturus Therapeutics Ltd. (edgar:1566049) Capital Expenditure: 688000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-04T08:20:02Z Snapshot: 04d173d115a783f66d72451f6752cdaff97f8c2503eee9d0f6fa24700edc3e3f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1566049/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 688000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000156459018013460/arct-20171231.xml#144665 Filing: 000156459018013460 The citation records this snapshot. The page link may show a newer release later.	−USD 3.55 million Calculation and evidence -2861000 − 688000 USD Exact free cash flow: -3549000 USD 2016-01-01 – 2016-12-31: -2861000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 688000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Arcturus Therapeutics Ltd. · 2016-12-31 Arcturus Therapeutics Ltd. (edgar:1566049) Free cash flow: -3549000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-04T08:20:02Z Snapshot: 04d173d115a783f66d72451f6752cdaff97f8c2503eee9d0f6fa24700edc3e3f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1566049?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2861000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000156459018013460/arct-20171231.xml#143702 Filing: 000156459018013460 Input fundies:CapitalExpenditure: 688000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000156459018013460/arct-20171231.xml#144665 Filing: 000156459018013460 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 10.9 million Exact value Exact value: -10902000 USD 2017-01-01 – 2017-12-31: -10902000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Arcturus Therapeutics Ltd. · 2017-12-31 Arcturus Therapeutics Ltd. (edgar:1566049) Net Income: -10902000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-04T08:20:02Z Snapshot: 04d173d115a783f66d72451f6752cdaff97f8c2503eee9d0f6fa24700edc3e3f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1566049/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -10902000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000119312519077140/arct-20181231.xml#128714 Filing: 000119312519077140 The citation records this snapshot. The page link may show a newer release later.	−USD 460,000 Exact value Exact value: -460000 USD 2017-01-01 – 2017-12-31: -460000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Arcturus Therapeutics Ltd. · 2017-12-31 Arcturus Therapeutics Ltd. (edgar:1566049) Operating Cash Flow: -460000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-04T08:20:02Z Snapshot: 04d173d115a783f66d72451f6752cdaff97f8c2503eee9d0f6fa24700edc3e3f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1566049/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -460000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000119312519077140/arct-20181231.xml#146084 Filing: 000119312519077140 The citation records this snapshot. The page link may show a newer release later.	USD 251,000 Exact value Exact value: 251000 USD 2017-01-01 – 2017-12-31: 251000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Arcturus Therapeutics Ltd. · 2017-12-31 Arcturus Therapeutics Ltd. (edgar:1566049) Capital Expenditure: 251000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-04T08:20:02Z Snapshot: 04d173d115a783f66d72451f6752cdaff97f8c2503eee9d0f6fa24700edc3e3f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1566049/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 251000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000119312519077140/arct-20181231.xml#146502 Filing: 000119312519077140 The citation records this snapshot. The page link may show a newer release later.	−USD 711,000 Calculation and evidence -460000 − 251000 USD Exact free cash flow: -711000 USD 2017-01-01 – 2017-12-31: -460000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 251000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Arcturus Therapeutics Ltd. · 2017-12-31 Arcturus Therapeutics Ltd. (edgar:1566049) Free cash flow: -711000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-04T08:20:02Z Snapshot: 04d173d115a783f66d72451f6752cdaff97f8c2503eee9d0f6fa24700edc3e3f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1566049?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -460000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000119312519077140/arct-20181231.xml#146084 Filing: 000119312519077140 Input fundies:CapitalExpenditure: 251000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000119312519077140/arct-20181231.xml#146502 Filing: 000119312519077140 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 21.79 million Exact value Exact value: -21785000 USD 2018-01-01 – 2018-12-31: -21785000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Arcturus Therapeutics Ltd. · 2018-12-31 Arcturus Therapeutics Ltd. (edgar:1566049) Net Income: -21785000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-04T08:20:02Z Snapshot: 04d173d115a783f66d72451f6752cdaff97f8c2503eee9d0f6fa24700edc3e3f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1566049/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -21785000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000119312519077140/arct-20181231.xml#128561 Filing: 000119312519077140 The citation records this snapshot. The page link may show a newer release later.	−USD 20.76 million Exact value Exact value: -20760000 USD 2018-01-01 – 2018-12-31: -20760000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Arcturus Therapeutics Ltd. · 2018-12-31 Arcturus Therapeutics Ltd. (edgar:1566049) Operating Cash Flow: -20760000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-04T08:20:02Z Snapshot: 04d173d115a783f66d72451f6752cdaff97f8c2503eee9d0f6fa24700edc3e3f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1566049/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -20760000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000119312519077140/arct-20181231.xml#145873 Filing: 000119312519077140 The citation records this snapshot. The page link may show a newer release later.	USD 1.48 million Exact value Exact value: 1478000 USD 2018-01-01 – 2018-12-31: 1478000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Arcturus Therapeutics Ltd. · 2018-12-31 Arcturus Therapeutics Ltd. (edgar:1566049) Capital Expenditure: 1478000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-04T08:20:02Z Snapshot: 04d173d115a783f66d72451f6752cdaff97f8c2503eee9d0f6fa24700edc3e3f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1566049/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1478000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000119312519077140/arct-20181231.xml#146293 Filing: 000119312519077140 The citation records this snapshot. The page link may show a newer release later.	−USD 22.24 million Calculation and evidence -20760000 − 1478000 USD Exact free cash flow: -22238000 USD 2018-01-01 – 2018-12-31: -20760000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 1478000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Arcturus Therapeutics Ltd. · 2018-12-31 Arcturus Therapeutics Ltd. (edgar:1566049) Free cash flow: -22238000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-04T08:20:02Z Snapshot: 04d173d115a783f66d72451f6752cdaff97f8c2503eee9d0f6fa24700edc3e3f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1566049?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -20760000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000119312519077140/arct-20181231.xml#145873 Filing: 000119312519077140 Input fundies:CapitalExpenditure: 1478000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1566049/000119312519077140/arct-20181231.xml#146293 Filing: 000119312519077140 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

116 filings · 745 latest values · 745 originally reported values

Dataset published 2026-11-04. Source filing dates and reporting periods are shown separately.

Identifiers: 0001566049, 1566049, ADHD, ARCT, edgar:1566049

Also known as ALCOBRA LTD., Arcturus Therapeutics Ltd.

Arcturus Therapeutics Ltd.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2018 2018-01-01 – 2018-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation